Epidemiology of vascular disease

Disease Management and Health Outcomes

Volumn 2, Issue SUPPL. 1, 1997, Pages 9-17

  Caspary, Ludwig ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002600509     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-199700021-00004     Document Type: Article

References (44)

1. Rose GA. The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bull Org Mond Sante 1962; 27: 645-58
2. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-5
3. Widmer LK, Stähelin HB, Nissen C, et al. Venen-Arterienkrankheiten koronare Herzkrankheit bei Berufstätigen. Basler Studie I-III 1959-1978. Bern, Stuttgart, Wien: Huber, 1981
4. Fowkes FG, Housley E, Cawood EH, et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-92
5. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the aging process: a review. J Clin Epidemiol 1992; 45: 529-42
6. Wolf PA, Kannel WB, Cupples LA, et al. Risk factor interaction in cardiovascular and cerebrovascular disease. In: Furlan AJ, editor. The heart and stroke. Berlin, Heidelberg: Springer, 1987: 331-55
7. Sytkowski PA, Kannel WB, D'Agoslino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. N Engl J Med 1990; 322: 1635-41
8. Goldberg RJ, Gorak EJ, Yarzbski J, et al. A community wide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation 1993; 87: 1947-53
9. Menotti A, Keys A, Blackburn H, et al. Comparison of multivariate predictive power of major risk factors for coronary heart disease in different countries: results from eight nations of the Seven Countries Study, 25-year follow-up. J Cardiovasc Risk 1996; 3: 69-75
10. Bamford J, Sandercock P, Dennis M, et al. A prospective study of acute cerebrovascular disease in the community. The Oxfordshire community stroke project 1981-86. 1. Methodology, demography and incidence of first-ever stroke. J Neurol Neurosurg Psych 1988; 51: 1373-80
11. Thorvaldsen P, Asplund K, Kuulasmaa K, et al. Stroke incidence, case fatality and mortality in the WHO MONICA project. Stroke 1995; 26: 361-7
12. Khaw KT. Epidemiology of stroke. J Neurol Neurosurg Psych 1996; 61: 333-8
13. O'Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 1992; 23: 1752-60
14. Wolf PA. Contributions to the epidemiology of stroke. Circulation 1993; 88: 2471-8
15. Simons LA. Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. Am J Cardiol 1986; 57: 5G-10
16. Vitale E, Zuliani G, Baroni L, et al. Lipoprotein abnormalities in patients with extracoronary arteriosclerosis. Atherosclerosis 1990; 81: 95-102
17. Iso H, Jacobs D, Wentworth D, et al. Serum cholesterol levels and six-years mortality from stroke in 350 977 men screened for the multiple intervention risk factor trial. N Engl J Med 1989; 320: 904-10
18. Kannel WB. Potency of vascular risk factors as the basis for antihypertensive therapy. Eur Heart J 1992; 13 Suppl. G: 34-42
19. Kleinman JC, Donahue RP, Harris MI, et al. Mortality among diabetics in a national health sample. Am J Epidemiol 1988; 128: 389-401
20. Walters DP, Gatling W, Mullee-MA, et al. The prevalence, detection, and epidemiological correlates of peripheral vascular disease: a comparison of diabetic and non-diabetic subjects in an English community. Diabet Med 1992; 9: 710-5
21. Hjermann I. The metabolic cardiovascular syndrome: syndrome X, Reaven's syndrome, insulin resistance syndrome, atherothrombogenic syndrome. J Cardiovasc Pharmacol 1992; 20 Suppl. 8: S5-10
22. Gagnon R, Zhang TJ, Brand FN, et al. Hematocrit and the risk of cardiovascular disease - The Framingham study: a 34-year follow-up. Am Heart J 1994; 127: 674-82
23. Nityanand S, Bergmark C, de Faire U, et al. Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. J Intern Med 1995; 238: 437-43
24. Brattstrom LE, Israelsson B, Norrving B, et al. Impaired homocystein metabolism in early-onset cerebral and peripheral occlusive arterial disease. Stroke 1984; 15: 1012-6
25. Fortin LJ, Genest J. Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin Biochem 1995; 28: 155-62
26. Scanu AM, Lawn RM, Berg K. Lipoprotein (a) and atherosclerosis. Ann Int Med 1991; 115: 209-18
27. Farmer JA, Gotto AM. Risk factors for coronary artery disease. In: Braunwald E, editor. The heart. Philadelphia: Saunders, 1992: 1125-60
28. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population based prospective studies. J Cardiovasc Risk 1996; 3: 213-9
29. Belch JJF. The relationship between white blood cells and arterial disease. Curr Opin Lipidol 1994; 5: 440-6
30. Ingolfsson IO, Sigurdsson G, Sigvaldason H, et al. A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol - the Reykjavik study. J Clin Epidemiol 1994; 47: 1237-43
31. Jonason T, Bergstrom R. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand 1987; 221: 253-60
32. Stark RM. Review of the major intervention trials of lowering coronary artery disease risk through cholesterol reduction. Am J Cardiol 1996; 78 (6A): 13-9
33. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827-38
34. Lip GYH, Beevers G, Zarifis J. Hormone replacement therapy and the cardiovascular risk: the cardiovascular physician's viewpoint. J Int Med 1995; 283: 389-99
35. Sellier P, Corona P, Audoin P, et al. Influence of training on blood lipids and coagulation. Eur Heart J 1988; 9 Suppl. M: 32-6
36. McGovern PG, Pankow JS, Sahar E. Recent trends in acute coronary heart disease mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey investigators. N Engl J Med 1996; 334: 884-90
37. Hertzer NR, Young JR, Beven EG, et al. Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch Int Med 1985; 145: 849-52
38. Chimowitz MI, Mancini GBJ. Asymptomatic coronary artery disease in patients with stroke. Stroke 1992; 23: 433-6
39. Salasidis GC, Latter DA, Steinmetz OK, et al. Carotid artery duplex scanning in preoperative assessment for coronary artery revascularisation: the association between peripheral vascular disease, carotid artery stenosis, and stroke. J Vasc Surg 1995; 21: 154-62
40. Alexandrova NA, Gibson WC, Norris JW, et al. Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 1996; 23: 645-9
41. Gersh BJ, Rihal CS, Rooke TW, et al. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol 1991; 18: 203-14
42. Behar S, Zion M, Reicher-Reiss H, et al. Short- and long-term prognosis of patients with a first acute myocardial infarction with concomitant peripheral vascular disease. SPRINT Study Group. Am J Med 1994; 96: 15-9
43. Leng GC, Fowkes FGR, Lee AJ, et al. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996; 313: 1440-4
44. Birkmeyer JD, Quinton HB, O'Connor NJ, et al. The effect of peripheral vascular disease on long-term mortality after coronary artery bypass surgery. Arch Surg 1996; 131: 316-21